Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy

被引：2
|
作者：
Peter, Karlheinz [1 ]
Lip, Gregory Y. H. [2 ]
机构：
[1] Baker Heart Res Inst, Ctr Thrombosis & Myocardial Infarct, Melbourne, Vic 8008, Australia
[2] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham, W Midlands, England
来源：
THROMBOSIS AND HAEMOSTASIS | 2010年 / 103卷 / 05期
关键词：
HOMOCYSTEINE;
D O I：
10.1160/TH10-03-0205
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：875 / 876
页数：2
相关论文
共 50 条
  • [1] Pharmaceutical thrombosis prevention in cardiovascular disease
    Eriksson, M
    Christensen, K
    Lindahl, TL
    Larsson, A
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (04) : 553 - 563
  • [2] Antioxidant therapy for the prevention of cardiovascular disease
    Nuttall, SL
    Kendall, MJ
    Martin, U
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1999, 92 (05) : 239 - 244
  • [3] Gene therapy for cardiovascular disease: Perspectives and potential
    Bradshaw, Angela C.
    Baker, Andrew H.
    [J]. VASCULAR PHARMACOLOGY, 2013, 58 (03) : 174 - 181
  • [4] Lifetime Perspectives on Primary Prevention of Atherosclerotic Cardiovascular Disease
    Leening, Maarten J. G.
    Berry, Jarett D.
    Allen, Norrina B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (14): : 1449 - 1450
  • [5] Thrombosis and cardiovascular disease
    Pifarré, R
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1998, 82 (03) : 511 - +
  • [6] Statin Therapy for Primary Prevention of Cardiovascular Disease
    Taylor, Fiona C.
    Huffman, Mark
    Ebrahim, Shah
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (22): : 2451 - 2452
  • [7] Lipid therapy - Prevention of arteriosclerotic cardiovascular disease
    Windler, E
    [J]. INTERNIST, 2001, 42 (01): : 92 - 110
  • [8] Hormone replacement therapy and the prevention of cardiovascular disease
    Teede, HJ
    [J]. HUMAN REPRODUCTION UPDATE, 2002, 8 (03) : 201 - 215
  • [9] INCIDENCE OF CARDIOVASCULAR DISEASE IN PATIENTS WITH DYSLIPIDEMIA RECEIVING MULTIFACTORIAL CARDIOVASCULAR PREVENTION THERAPY
    Barkas, F.
    Anastasiou, G.
    Adamidis, P.
    Elisaf, M.
    Koutsogianni, A. -D.
    Liberopoulos, E. N.
    [J]. ATHEROSCLEROSIS, 2021, 331 : E273 - E274
  • [10] Perspectives on cardiovascular disease
    Artigou, JY
    [J]. PRESSE MEDICALE, 2005, 34 (18): : 1277 - 1277
12345